Attralus Launches with $25 Million Series A Financing from venBio Partners to Transform Treatment for Patients with Systemic Amyloidosis

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3kbGFcC
via IFTTT